Panel Discussion: Navigating the Complexities of Market Access & Transitioning to Commercial Launch in the EU
- Exploring the challenges of transitioning from early access to full reimbursement within the EU’s complex regulatory and reimbursement landscape
- Strategies for managing country-specific reimbursement systems and understanding the interplay between different EU member states’ policies to ensure smooth market access
- Ensuring continuous patient access during the transition from early access programs to commercial launch, focusing on cost-effective solutions and compliance